<scp>Anti‐SARS‐CoV</scp> ‐19 antibodies in children and adults with sickle cell disease: A single‐site analysis in New York City-Reference-Cited by-同舟云学术

Anti‐SARS‐CoV ‐19 antibodies in children and adults with sickle cell disease: A single‐site analysis in New York City

Published:2022-06-27 Issue:4 Volume:198 Page:680-683
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Green Nancy S.¹²^ORCID,Van Doren Layla²,Licursi Maureen¹,Billings Daniel D.²,Sandoval Luke A.³,Feit Yona M. Z.³,Hod Eldad A.³

Affiliation:

1. Department of Pediatrics, Division of Hematology, Oncology and Stem Cell Transplantation Columbia University Irving Medical Center – New York Presbyterian Hospital New York New York USA

2. Department of Medicine, Division of Hematology and Oncology Columbia University Irving Medical Center – New York Presbyterian Hospital New York New York USA

3. Department of Pathology and Cell Biology Columbia University Irving Medical Center – New York Presbyterian Hospital New York New York USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.18294

Reference15 articles.

1. Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review

2. COVID-19 in individuals with sickle cell disease/trait compared with other Black individuals

3. Coronavirus Disease among Persons with Sickle Cell Disease, United States, March 20–May 21, 2020

4. Alteration of humoral, cellular and cytokine immune response to inactivated influenza vaccine in patients with Sickle Cell Disease

5. Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccination in sickle cell disease: Immunocompromised or immunocompetent?;British Journal of Haematology;2023-06-22